Phospholipase C: Difference between revisions

Joel L. Sussman (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 8: Line 8:
*'''Phospholipase C δ''' is critical for Ca+2 homeostasis.
*'''Phospholipase C δ''' is critical for Ca+2 homeostasis.
*'''Phospholipase C ε''' is an effector for Ras.
*'''Phospholipase C ε''' is an effector for Ras.
*'''Phosphatidylinositol-specific phospholipase C''' (PIPLC) catalyzes the hydrolysis of phosphatidylinositol into inositol triphosphate and deacylglycerol.  PIPLC functions at the plasma membrane.  PIPLC can release phosphatidylinositol-linked proteins (i.e., acetylcholinesterase) from the membrane by enzymatically cleaving their GPI anchor. <ref>PMID:11249190</ref>
*'''Phosphatidylinositol-specific phospholipase C''' (PIPLC) catalyzes the hydrolysis of phosphatidylinositol into inositol triphosphate and deacylglycerol.  PIPLC functions at the plasma membrane.  PIPLC can release phosphatidylinositol-linked proteins (i.e., acetylcholinesterase) from the membrane by enzymatically cleaving their GPI anchor. <ref>PMID:11249190</ref>. See also [[IP3 is second messenger]].


== Disease ==
== Disease ==
Line 51: Line 51:
**[[2zkm]] – hPLCB-2 - human<br />
**[[2zkm]] – hPLCB-2 - human<br />
**[[2fju]] – hPLCB-2 + RAC1<br />
**[[2fju]] – hPLCB-2 + RAC1<br />
**[[8emv]] – hPLCB-3 – Cryo EM <br />
**[[7sq2]], [[4gnk]], [[4qj3]] – hPLCB-3 + guanine nucleotide-binding protein G subunit alpha<br />
**[[7sq2]], [[4gnk]], [[4qj3]] – hPLCB-3 + guanine nucleotide-binding protein G subunit alpha<br />
**[[4qj4]], [[4qj5]] – hPLCB-3 + guanine nucleotide-binding protein G subunit alpha + inositol phosphate derivative <br />
**[[4qj4]], [[4qj5]] – hPLCB-3 + guanine nucleotide-binding protein G subunit alpha + inositol phosphate derivative <br />
**[[7sq2]] – hPLCB-3 + guanine nucleotide-binding protein G subunit alpha + GDP <br />
**[[8emw]], [[8emx]] – hPLCB-3 + guanine nucleotide-binding protein G subunits beta+gamma – Cryo EM <br />
**[[1jad]] – PLCB - turkey<br />
**[[1jad]] – PLCB - turkey<br />
**[[3qr0]] – PLCB - cuttlefish<br />
**[[3qr0]] – PLCB - cuttlefish<br />
Line 65: Line 68:
**[[2w2x]] – hPLCG-2 split PH2 domain + RAC2 br />
**[[2w2x]] – hPLCG-2 split PH2 domain + RAC2 br />
**[[4ey0]] – hPLCG-1 SH2 domain (mutant)<br />
**[[4ey0]] – hPLCG-1 SH2 domain (mutant)<br />
**[[7nxe]] – hPLCG-1 SH2 domain + peptide<br />
**[[2pld]], [[2ple]] – PLCG C terminal SH2 domain + PDGF peptide – bovine - NMR <br />
**[[2pld]], [[2ple]] – PLCG C terminal SH2 domain + PDGF peptide – bovine - NMR <br />
**[[1ywp]] – rPLCG-1 SH3 domain – rat<br />
**[[6pbc]] – rPLCG-1 – rat<br />
**[[1ywp]] – rPLCG-1 SH3 domain 790-851<br />
**[[1y0m]] – rPLCG-1 SH3 domain (mutant)<br />
**[[1y0m]] – rPLCG-1 SH3 domain (mutant)<br />
**[[2fjl]] – rPLCG-1 split PH2 domain - NMR<br />
**[[2fjl]] – rPLCG-1 split PH2 domain - NMR<br />
**[[2eob]] – rPLCG-2 SH2 domain - NMR<br />
**[[2eob]] – rPLCG-2 SH2 domain 633-743 - NMR<br />
**[[1ywo]] – rPLCG-1 SH3 domain + lymphocyte cytosolic protein peptide <br />
**[[1ywo]] – rPLCG-1 SH3 domain + lymphocyte cytosolic protein peptide <br />
**[[7z3j]] – rPLCG-1 + inositol-3P <br />
**[[4k44]], [[4k45]] – rPLCG C terminal SH2 domain <br />
**[[4k44]], [[4k45]] – rPLCG C terminal SH2 domain <br />
**[[2dx0]] – mPLCG-2 N terminal SH2 domain – mouse<br />
**[[2dx0]] – mPLCG-2 N terminal SH2 domain – mouse<br />
Line 86: Line 92:
**[[2bye]] – hPLCE-1 RA1 domain - NMR <br />
**[[2bye]] – hPLCE-1 RA1 domain - NMR <br />
**[[2byf]] – hPLCE-1 RA2 domain - NMR <br />
**[[2byf]] – hPLCE-1 RA2 domain - NMR <br />
**[[6pmp]] – rPLCE-1 RA1 domain <br />


* Phospholipase C  
* Phospholipase C  


**[[8hav]], [[8haw]] – BcPLC4 (mutant) – ''Arabidopsis thaliana''<br />
**[[1ah7]] – BcPLC<br />
**[[1ah7]] – BcPLC<br />
**[[1p5x]], [[2ffz]], [[2fgn]], [[2huc]] – BcPLC (mutant)<br />
**[[1p5x]], [[2ffz]], [[2fgn]], [[2huc]] – BcPLC (mutant)<br />

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Jaime Prilusky, Alexander Berchansky, Joel L. Sussman